BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3143662)

  • 1. Lysinuric protein intolerance mutation is not expressed in the plasma membrane of erythrocytes.
    Smith DW; Scriver CR; Simell O
    Hum Genet; 1988 Dec; 80(4):395-6. PubMed ID: 3143662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysinuric protein intolerance mutation is expressed in the plasma membrane of cultured skin fibroblasts.
    Smith DW; Scriver CR; Tenenhouse HS; Simell O
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7711-5. PubMed ID: 3478720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic amino acid transport through system y+L in erythrocytes of patients with lysinuric protein intolerance.
    Boyd CA; Deves R; Laynes R; Kudo Y; Sebastio G
    Pflugers Arch; 2000 Mar; 439(5):513-6. PubMed ID: 10764208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of novel mutations in y(+)LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI).
    Mykkänen J; Torrents D; Pineda M; Camps M; Yoldi ME; Horelli-Kuitunen N; Huoponen K; Heinonen M; Oksanen J; Simell O; Savontaus ML; Zorzano A; Palacín M; Aula P
    Hum Mol Genet; 2000 Feb; 9(3):431-8. PubMed ID: 10655553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance.
    Rotoli BM; Barilli A; Visigalli R; Ferrari F; Dall'Asta V
    J Cell Mol Med; 2020 Jan; 24(1):921-929. PubMed ID: 31705628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance.
    Barilli A; Rotoli BM; Visigalli R; Bussolati O; Gazzola GC; Gatti R; Dionisi-Vici C; Martinelli D; Goffredo BM; Font-Llitjós M; Mariani F; Luisetti M; Dall'Asta V
    Mol Genet Metab; 2012 Apr; 105(4):585-9. PubMed ID: 22325938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.
    Torrents D; Mykkänen J; Pineda M; Feliubadaló L; Estévez R; de Cid R; Sanjurjo P; Zorzano A; Nunes V; Huoponen K; Reinikainen A; Simell O; Savontaus ML; Aula P; Palacín M
    Nat Genet; 1999 Mar; 21(3):293-6. PubMed ID: 10080182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine fluxes across the jejunal epithelium in lysinuric protein intolerance.
    Desjeux JF; Simell RO; Dumontier AM; Perheentupa J
    J Clin Invest; 1980 Jun; 65(6):1382-7. PubMed ID: 6773985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the transcriptomic variation caused by the Finnish founder mutation of lysinuric protein intolerance (LPI).
    Tringham M; Kurko J; Tanner L; Tuikkala J; Nevalainen OS; Niinikoski H; Näntö-Salonen K; Hietala M; Simell O; Mykkänen J
    Mol Genet Metab; 2012 Mar; 105(3):408-15. PubMed ID: 22221392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic features of lysinuric protein intolerance in Japan.
    Noguchi A; Nakamura K; Murayama K; Yamamoto S; Komatsu H; Kizu R; Takayanagi M; Okuyama T; Endo F; Takasago Y; Shoji Y; Takahashi T
    Pediatr Int; 2016 Oct; 58(10):979-983. PubMed ID: 26865117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lysine infusion on urea cycle in lysinuric protein intolerance.
    Lukkarinen M; Näntö-Salonen K; Pulkki K; Mattila K; Simell O
    Metabolism; 2000 May; 49(5):621-5. PubMed ID: 10831173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of LPI-causing mutations on y+LAT1 function and localization.
    Rotoli BM; Barilli A; Ingoglia F; Visigalli R; Bianchi MG; Ferrari F; Martinelli D; Dionisi-Vici C; Dall'Asta V
    Orphanet J Rare Dis; 2019 Mar; 14(1):63. PubMed ID: 30832686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased NO production in lysinuric protein intolerance.
    Mannucci L; Emma F; Markert M; Bachmann C; Boulat O; Carrozzo R; Rizzoni G; Dionisi-Vici C
    J Inherit Metab Dis; 2005; 28(2):123-9. PubMed ID: 15877200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14.
    Lauteala T; Sistonen P; Savontaus ML; Mykkänen J; Simell J; Lukkarinen M; Simell O; Aula P
    Am J Hum Genet; 1997 Jun; 60(6):1479-86. PubMed ID: 9199570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ornithine metabolism in hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome, lysinuric protein intolerance and gyrate atrophy fibroblasts.
    Botschner J; Smith DW; Simell O; Scriver CR
    J Inherit Metab Dis; 1989; 12(1):33-40. PubMed ID: 2501580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slc7a7 disruption causes fetal growth retardation by downregulating Igf1 in the mouse model of lysinuric protein intolerance.
    Sperandeo MP; Annunziata P; Bozzato A; Piccolo P; Maiuri L; D'Armiento M; Ballabio A; Corso G; Andria G; Borsani G; Sebastio G
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C191-8. PubMed ID: 17376816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic homogeneity of lysinuric protein intolerance.
    Lauteala T; Mykkänen J; Sperandeo MP; Gasparini P; Savontaus ML; Simell O; Andria G; Sebastio G; Aula P
    Eur J Hum Genet; 1998; 6(6):612-5. PubMed ID: 9887380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the lysinuric protein intolerance (LPI) region within T-cell receptor alpha/delta gene cluster on chromosome site 14q11.
    Lauteala T; Mykkänen J; Horelli-Kuitunen N; Aaltonen J; Paavola P; Savontaus ML; Simell O; Aula P
    Hereditas; 1999; 130(1):19-24. PubMed ID: 10364825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction in macrophage toll-like receptor signaling caused by an inborn error of cationic amino acid transport.
    Kurko J; Vähä-Mäkilä M; Tringham M; Tanner L; Paavanen-Huhtala S; Saarinen M; Näntö-Salonen K; Simell O; Niinikoski H; Mykkänen J
    Mol Immunol; 2015 Oct; 67(2 Pt B):416-25. PubMed ID: 26210182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance.
    IJzermans T; van der Meijden W; Hoeks M; Huigen M; Rennings A; Nijenhuis T
    Am J Kidney Dis; 2023 Apr; 81(4):493-496. PubMed ID: 36223829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.